Asia-Pacific Preclinical Imaging Market - Industry Trends and Forecast to 2030

TABLE OF CONTENTS

1 INTRODUCTION 25

• 1.1 OBJECTIVES OF THE STUDY 25
• 1.2 MARKET DEFINITION 25
• 1.3 OVERVIEW OF THE ASIA-PACIFIC PRECLINICAL IMAGING MARKET 25
• 1.4 CURRENCY AND PRICING 26
• 1.5 LIMITATIONS 27
• 1.6 MARKETS COVERED 27

2 MARKET SEGMENTATION 29

• 2.1 MARKETS COVERED 29
• 2.2 GEOGRAPHICAL SCOPE 30
• 2.3 YEARS CONSIDERED FOR THE STUDY 30
• 2.4 DBMR TRIPOD DATA VALIDATION MODEL 31
• 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34
• 2.6 MULTIVARIATE MODELLING 35
• 2.7 PRODUCT SEGMENT LIFELINE CURVE 36
• 2.8 MARKET END USER COVERAGE GRID 37
• 2.9 DBMR MARKET POSITION GRID 38
• 2.10 VENDOR SHARE ANALYSIS 39
• 2.11 SECONDARY SOURCES 40
• 2.12 ASSUMPTIONS 40

3 EXECUTIVE SUMMARY 41

4 PREMIUM INSIGHTS 43

• 4.1 PESTEL ANALYSIS 44
• 4.2 PORTER'S FIVE FIRCES 45
• 4.3 STRATEGIC INITIATIVES 46

5 REGULATORY FRAMEWORK 47

• 5.1 REGULATORY SCENARIO IN AUSTRALIA 47

6 MARKET OVERVIEW 48

• 6.1 DRIVERS 50
  • 6.1.1 INCREASING TECHNOLOGICAL ADVANCEMENT IN THE FIELD OF IMAGING 50
  • 6.1.2 INCREASING NUMBER OF INVESTMENTS AND FUNDING IN RESEARCH AND DEVELOPMENT 50
  • 6.1.3 INCREASING INCIDENCE OF CHRONIC DISEASES 51
• 6.2 RESTRAINTS 52
  • 6.2.1 STRINGENT REGULATORY FRAMEWORK FOR PRODUCT APPROVAL 52
  • 6.2.2 HIGH INSTALLATION AND OPERATIONAL COST OF PRECLINICAL IMAGING SYSTEMS 52
• 6.3 OPPORTUNITIES 53
  • 6.3.1 INCREASING ADOPTION OF IMAGING SYSTEMS FOR PRECLINICAL PURPOSES 53
  • 6.3.2 GROWING DEMAND FOR NON-INVASIVE SMALL-ANIMAL IMAGING METHODS 53
• 6.4 CHALLENGES 54
  • 6.4.1 LACK OF SKILLED PROFESSIONALS FOR THE EFFECTIVE UTILIZATION OF PRECLINICAL IMAGING SYSTEMS 54
  • 6.4.2 INTEGRATION OF IMAGING DEVICES WITH OTHER TECHNOLOGIES 54

7 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY PRODUCT 55

• 7.1 OVERVIEW 56
• 7.2 SYSTEMS 59
  • 7.2.1 OPTICAL IMAGING SYSTEMS 60
    • 7.2.1.1 BIOLUMINESCENCE/FLUORESCENCE IMAGING SYSTEMS 60
    • 7.2.1.2 STANDALONE FLUORESCENCE IMAGING SYSTEMS 60
    • 7.2.1.3 OPTICAL + X-RAY/OPTICAL + CT 60
  • 7.2.2 PRECLINICAL NUCLEAR IMAGING SYSTEMS 61
    • 7.2.2.1 MICRO-POSITRON EMISSION TOMOGRAPHY (PET) SYSTEMS 61
    • 7.2.2.2 MICRO-SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SYSTEMS 61
    • 7.2.2.3 TRIPRODUCT (SPECT/PET/CT) SYSTEMS 61
  • 7.2.3 MICRO-MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 61
  • 7.2.4 MICRO-COMPUTED TOMOGRAPHY (CT) SYSTEMS 61
  • 7.2.5 MICRO-ULTRASOUND SYSTEMS 62
  • 7.2.6 PRECLINICAL PHOTOACOUSTIC IMAGING SYSTEMS 62
  • 7.2.7 PRECLINICAL MAGNETIC PARTICLE IMAGING (MPI) SYSTEMS 62
  • 7.2.8 MAGNETIC RESONANCE SPECTROSCOPY IMAGING (MRSI) 62
• 7.3 SERVICES 62

8 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY REAGENTS 63

• 8.1 OVERVIEW 64
• 8.2 PRECLINICAL OPTICAL IMAGING REAGENTS 67
  • 8.2.1 BIOLUMINESCENT IMAGING REAGENTS 67
  • 8.2.2 FLUORESCENT IMAGING REAGENTS 67
• 8.3 PRECLINICAL NUCLEAR IMAGING REAGENTS 68
  • 8.3.1 PRECLINICAL PET TRACERS 68
  • 8.3.2 PRECLINICAL SPECT PROBES 68
• 8.4 PRECLINICAL MRI CONTRAST AGENTS 69
  • 8.4.1 GADOLINIUM-BASED PRECLINICAL MRI CONTRAST AGENTS 69
  • 8.4.2 MANGANESE-BASED PRECLINICAL MRI CONTRAST AGENTS 69
  • 8.4.3 IRON-BASED PRECLINICAL MRI CONTRAST AGENTS 69
• 8.5 PRECLINICAL ULTRASOUND CONTRAST AGENTS 69
• 8.6 PRECLINICAL CT CONTRAST AGENTS 70
  • 8.6.1 IODINE-BASED PRECLINICAL CT CONTRAST AGENTS 70
  • 8.6.2 BARIUM-BASED PRECLINICAL CT CONTRAST AGENTS 70
  • 8.6.3 GOLD NANOPARTICLES 70
  • 8.6.4 GASTROGRAFIN-BASED PRECLINICAL CT CONTRAST AGENTS 70

9 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY APPLICATION 71

• 9.1 OVERVIEW 72
• 9.2 RESEARCH AND DEVELOPMENT 75
• 9.3 DRUG DISCOVERY 75
• 9.4 BIO-DISTRIBUTION 75
• 9.5 CANCER CELL DETECTION 75
• 9.6 BIO-MARKERS 75
• 9.7 OTHERS 75

10 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY END USER 76

• 10.1 OVERVIEW 77
• 10.2 CONTRACT RESEARCH ORGANIZATION 80
• 10.3 PHARMACEUTICAL & BIOTECH COMPANIES 80
• 10.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 80
• 10.5 DIAGNOSTICS CENTER 80
• 10.6 OTHERS 80

11 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY COUNTRY 81

• 11.1 ASIA-PACIFIC 81
  • 11.1.1 CHINA 83
  • 11.1.2 JAPAN 92
  • 11.1.3 SOUTH KOREA 101
  • 11.1.4 INDIA 110
  • 11.1.5 AUSTRALIA 119
  • 11.1.6 SINGAPORE 128
  • 11.1.7 THAILAND 137
  • 11.1.8 MALAYSIA 146
  • 11.1.9 INDONESIA 155
  • 11.1.10 PHILIPPINES 164
  • 11.1.11 RSET OF ASIA PACIFIC 173

12 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, COMPANY LANDSCAPE 174

• 12.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 174

13 SWOT ANALYSIS 175

14 COMPANY PROFILE 176

• 14.1 PERKINELMER INC. 176
  • 14.1.1 COMPANY SNAPSHOT 176
  • 14.1.2 REVENUE ANALYSIS 176
  • 14.1.3 PRODUCT PORTFOLIO 177
  • 14.1.4 RECENT DEVELOPMENT 178
• 14.2 FUJIFILM VISUALSONICS, INC 179
  • 14.2.1 COMPANY SNAPSHOT 179
  • 14.2.2 REVENUE ANALYSIS 179
  • 14.2.3 PRODUCT PORTFOLIO 180
  • 14.2.4 RECENT DEVELOPMENT 180
• 14.3 HOLOGIC, INC. 181
  • 14.3.1 COMPANY SNAPSHOT 181
  • 14.3.2 REVENUE ANALYSIS 181
  • 14.3.3 PRODUCT PORTFOLIO 182
  • 14.3.4 RECENT DEVELOPMENT 182
• 14.4 BRUKER 183
  • 14.4.1 COMPANY SNAPSHOT 183
  • 14.4.2 REVENUE ANALYSIS 183
  • 14.4.3 PRODUCT PORTFOLIO 184
  • 14.4.4 RECENT DEVELOPMENT 184
• 14.5 ZEISS GROUP 185
  • 14.5.1 COMPANY SNAPSHOT 185
  • 14.5.2 REVENUE ANALYSIS 185
  • 14.5.3 PRODUCT PORTFOLIO 186
  • 14.5.4 RECENT DEVELOPMENT 186
• 14.6 ADVANCED MOLECULAR VISION, INC. 187
  • 14.6.1 COMPANY SNAPSHOT 187
  • 14.6.2 PRODUCT PORTFOLIO 187
  • 14.6.3 RECENT DEVELOPMENT 187
• 14.7 AGILENT TECHNOLOGIES, INC. 188
  • 14.7.1 COMPANY SNAPSHOT 188
  • 14.7.2 REVENUE ANALYSIS 188
  • 14.7.3 PRODUCT PORTFOLIO 189
  • 14.7.4 RECENT DEVELOPMENT 189
• 14.8 AI4R 190
  • 14.8.1 COMPANY SNAPSHOT 190
  • 14.8.2 PRODUCT PORTFOLIO 190
  • 14.8.3 RECENT DEVELOPMENT 190
• 14.9 BERTHOLD TECHNOLOGIES GMBH & CO.KG 191
  • 14.9.1 COMPANY SNAPSHOT 191
  • 14.9.2 PRODUCT PORTFOLIO 191
  • 14.9.3 RECENT DEVELOPMENT 191
• 14.10 HAMAMATSU PHOTONICS K.K. 192
  • 14.10.1 COMPANY SNAPSHOT 192
  • 14.10.2 REVENUE ANALYSIS 192
  • 14.10.3 PRODUCT PORTFOLIO 193
  • 14.10.4 RECENT DEVELOPMENT 193
• 14.11 IVIM TECHNOLOGY CORP. 194
  • 14.11.1 COMPANY SNAPSHOT 194
  • 14.11.2 PRODUCT PORTFOLIO 194
  • 14.11.3 RECENT DEVELOPMENT 194
• 14.12 LI-COR, INC. 195
  • 14.12.1 COMPANY SNAPSHOT 195
  • 14.12.2 PRODUCT PORTFOLIO 195
  • 14.12.3 RECENT DEVELOPMENT 195
• 14.13 MEDISO LTD. 196
  • 14.13.1 COMPANY SNAPSHOT 196
  • 14.13.2 PRODUCT PORTFOLIO 196
  • 14.13.3 RECENT DEVELOPMENT 196
• 14.14 MILABS B.V. 197
  • 14.14.1 COMPANY SNAPSHOT 197
  • 14.14.2 PRODUCT PORTFOLIO 197
  • 14.14.3 RECENT DEVELOPMENT 197
• 14.15 MR SOLUTIONS 198
  • 14.15.1 COMPANY SNAPSHOT 198
  • 14.15.2 PRODUCT PORTFOLIO 198
  • 14.15.3 RECENT DEVELOPMENT 198
• 14.16 PHOTON ETC 199
  • 14.16.1 COMPANY SNAPSHOT 199
  • 14.16.2 PRODUCT PORTFOLIO 199
  • 14.16.3 RECENT DEVELOPMENT 199
• 14.17 TRIFOIL IMAGING 200
  • 14.17.1 COMPANY SNAPSHOT 200
  • 14.17.2 PRODUCT PORTFOLIO 200
  • 14.17.3 RECENT DEVELOPMENT 200
• 14.18 VIEWORKS CO., LTD. 201
  • 14.18.1 COMPANY SNAPSHOT 201
  • 14.18.2 REVENUE ANALYSIS 201
  • 14.18.3 PRODUCT PORTFOLIO 202
  • 14.18.4 RECENT DEVELOPMENT 202

15 QUESTIONNAIRE 203

16 RELATED REPORTS 206

LIST OF TABLES

• TABLE 1 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 58
• TABLE 2 ASIA-PACIFIC SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 59
• TABLE 3 ASIA-PACIFIC OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 60
• TABLE 4 ASIA-PACIFIC PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 61
• TABLE 5 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 66
• TABLE 6 ASIA-PACIFIC PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 67
• TABLE 7 ASIA-PACIFIC PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 68
• TABLE 8 ASIA-PACIFIC PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 69
• TABLE 9 ASIA-PACIFIC PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 70
• TABLE 10 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 74
• TABLE 11 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 79
• TABLE 12 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 82
• TABLE 13 CHINA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 83
• TABLE 14 CHINA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 83
• TABLE 15 CHINA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 84
• TABLE 16 CHINA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 84
• TABLE 17 CHINA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 85
• TABLE 18 CHINA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 85
• TABLE 19 CHINA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 85
• TABLE 20 CHINA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 85
• TABLE 21 CHINA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 86
• TABLE 22 CHINA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 86
• TABLE 23 CHINA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 86
• TABLE 24 CHINA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 87
• TABLE 25 CHINA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 87
• TABLE 26 CHINA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 87
• TABLE 27 CHINA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 87
• TABLE 28 CHINA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 88
• TABLE 29 CHINA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 88
• TABLE 30 CHINA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 88
• TABLE 31 CHINA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 88
• TABLE 32 CHINA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 89
• TABLE 33 CHINA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 89
• TABLE 34 CHINA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 89
• TABLE 35 CHINA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 90
• TABLE 36 CHINA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 90
• TABLE 37 CHINA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 90
• TABLE 38 CHINA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 91
• TABLE 39 CHINA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 91
• TABLE 40 JAPAN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 92
• TABLE 41 JAPAN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 92
• TABLE 42 JAPAN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 93
• TABLE 43 JAPAN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 93
• TABLE 44 JAPAN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 94
• TABLE 45 JAPAN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 94
• TABLE 46 JAPAN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 94
• TABLE 47 JAPAN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 94
• TABLE 48 JAPAN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 95
• TABLE 49 JAPAN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 95
• TABLE 50 JAPAN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 95
• TABLE 51 JAPAN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 96
• TABLE 52 JAPAN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 96
• TABLE 53 JAPAN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 96
• TABLE 54 JAPAN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 97
• TABLE 55 JAPAN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 97
• TABLE 56 JAPAN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 97
• TABLE 57 JAPAN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 97
• TABLE 58 JAPAN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 97
• TABLE 59 JAPAN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 98
• TABLE 60 JAPAN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 98
• TABLE 61 JAPAN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 98
• TABLE 62 JAPAN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 99
• TABLE 63 JAPAN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 99
• TABLE 64 JAPAN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 99
• TABLE 65 JAPAN PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 100
• TABLE 66 JAPAN PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 100
• TABLE 67 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 101
• TABLE 68 SOUTH KOREA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 101
• TABLE 69 SOUTH KOREA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 102
• TABLE 70 SOUTH KOREA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 102
• TABLE 71 SOUTH KOREA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 103
• TABLE 72 SOUTH KOREA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 103
• TABLE 73 SOUTH KOREA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 103
• TABLE 74 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 103
• TABLE 75 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 104
• TABLE 76 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 104
• TABLE 77 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 104
• TABLE 78 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 105
• TABLE 79 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 105
• TABLE 80 SOUTH KOREA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 105
• TABLE 81 SOUTH KOREA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 105
• TABLE 82 SOUTH KOREA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 106
• TABLE 83 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 106
• TABLE 84 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 106
• TABLE 85 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 106
• TABLE 86 SOUTH KOREA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 107
• TABLE 87 SOUTH KOREA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 107
• TABLE 88 SOUTH KOREA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 107
• TABLE 89 SOUTH KOREA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 108
• TABLE 90 SOUTH KOREA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 108
• TABLE 91 SOUTH KOREA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 108
• TABLE 92 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 109
• TABLE 93 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 109
• TABLE 94 INDIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 110
• TABLE 95 INDIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 110
• TABLE 96 INDIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 111
• TABLE 97 INDIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 111
• TABLE 98 INDIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 112
• TABLE 99 INDIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 112
• TABLE 100 INDIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 112
• TABLE 101 INDIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 113
• TABLE 102 INDIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 113
• TABLE 103 INDIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 113
• TABLE 104 INDIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 114
• TABLE 105 INDIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 114
• TABLE 106 INDIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 114
• TABLE 107 INDIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 115
• TABLE 108 INDIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 115
• TABLE 109 INDIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 115
• TABLE 110 INDIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 115
• TABLE 111 INDIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 116
• TABLE 112 INDIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 116
• TABLE 113 INDIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 116
• TABLE 114 INDIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 116
• TABLE 115 INDIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 117
• TABLE 116 INDIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 117
• TABLE 117 INDIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 117
• TABLE 118 INDIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 118
• TABLE 119 INDIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 118
• TABLE 120 INDIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 118
• TABLE 121 AUSTRALIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 119
• TABLE 122 AUSTRALIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 119
• TABLE 123 AUSTRALIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 120
• TABLE 124 AUSTRALIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 120
• TABLE 125 AUSTRALIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 121
• TABLE 126 AUSTRALIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 121
• TABLE 127 AUSTRALIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 121
• TABLE 128 AUSTRALIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 121
• TABLE 129 AUSTRALIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 122
• TABLE 130 AUSTRALIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 122
• TABLE 131 AUSTRALIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 122
• TABLE 132 AUSTRALIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 123
• TABLE 133 AUSTRALIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 123
• TABLE 134 AUSTRALIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 123
• TABLE 135 AUSTRALIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 123
• TABLE 136 AUSTRALIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 124
• TABLE 137 AUSTRALIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 124
• TABLE 138 AUSTRALIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 124
• TABLE 139 AUSTRALIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 124
• TABLE 140 AUSTRALIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 125
• TABLE 141 AUSTRALIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 125
• TABLE 142 AUSTRALIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 125
• TABLE 143 AUSTRALIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 126
• TABLE 144 AUSTRALIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 126
• TABLE 145 AUSTRALIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 126
• TABLE 146 AUSTRALIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 127
• TABLE 147 AUSTRALIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 127
• TABLE 148 SINGAPORE PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 128
• TABLE 149 SINGAPORE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 128
• TABLE 150 SINGAPORE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 129
• TABLE 151 SINGAPORE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 129
• TABLE 152 SINGAPORE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 130
• TABLE 153 SINGAPORE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 130
• TABLE 154 SINGAPORE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 130
• TABLE 155 SINGAPORE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 130
• TABLE 156 SINGAPORE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 131
• TABLE 157 SINGAPORE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 131
• TABLE 158 SINGAPORE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 131
• TABLE 159 SINGAPORE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 132
• TABLE 160 SINGAPORE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 132
• TABLE 161 SINGAPORE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 132
• TABLE 162 SINGAPORE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 132
• TABLE 163 SINGAPORE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 133
• TABLE 164 SINGAPORE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 133
• TABLE 165 SINGAPORE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 133
• TABLE 166 SINGAPORE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 133
• TABLE 167 SINGAPORE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 134
• TABLE 168 SINGAPORE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 134
• TABLE 169 SINGAPORE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 134
• TABLE 170 SINGAPORE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 135
• TABLE 171 SINGAPORE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 135
• TABLE 172 SINGAPORE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 135
• TABLE 173 SINGAPORE PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 136
• TABLE 174 SINGAPORE PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 136
• TABLE 175 THAILAND PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 137
• TABLE 176 THAILAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 137
• TABLE 177 THAILAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 138
• TABLE 178 THAILAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 138
• TABLE 179 THAILAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 139
• TABLE 180 THAILAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 139
• TABLE 181 THAILAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 139
• TABLE 182 THAILAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 139
• TABLE 183 THAILAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 140
• TABLE 184 THAILAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 140
• TABLE 185 THAILAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 140
• TABLE 186 THAILAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 141
• TABLE 187 THAILAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 141
• TABLE 188 THAILAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 141
• TABLE 189 THAILAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 141
• TABLE 190 THAILAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 142
• TABLE 191 THAILAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 142
• TABLE 192 THAILAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 142
• TABLE 193 THAILAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 142
• TABLE 194 THAILAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 143
• TABLE 195 THAILAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 143
• TABLE 196 THAILAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 143
• TABLE 197 THAILAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 144
• TABLE 198 THAILAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 144
• TABLE 199 THAILAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 144
• TABLE 200 THAILAND PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 145
• TABLE 201 THAILAND PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 145
• TABLE 202 MALAYSIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 146
• TABLE 203 MALAYSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 146
• TABLE 204 MALAYSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 147
• TABLE 205 MALAYSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 147
• TABLE 206 MALAYSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 148
• TABLE 207 MALAYSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 148
• TABLE 208 MALAYSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 148
• TABLE 209 MALAYSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 148
• TABLE 210 MALAYSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 149
• TABLE 211 MALAYSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 149
• TABLE 212 MALAYSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 149
• TABLE 213 MALAYSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 150
• TABLE 214 MALAYSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 150
• TABLE 215 MALAYSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 150
• TABLE 216 MALAYSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 150
• TABLE 217 MALAYSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 151
• TABLE 218 MALAYSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 151
• TABLE 219 MALAYSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 151
• TABLE 220 MALAYSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 151
• TABLE 221 MALAYSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 152
• TABLE 222 MALAYSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 152
• TABLE 223 MALAYSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 152
• TABLE 224 MALAYSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 153
• TABLE 225 MALAYSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 153
• TABLE 226 MALAYSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 153
• TABLE 227 MALAYSIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 154
• TABLE 228 MALAYSIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 154
• TABLE 229 INDONESIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 155
• TABLE 230 INDONESIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 155
• TABLE 231 INDONESIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 156
• TABLE 232 INDONESIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 156
• TABLE 233 INDONESIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 157
• TABLE 234 INDONESIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 157

• TABLE 235 INDONESIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 157
• TABLE 236 INDONESIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 157
• TABLE 237 INDONESIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 158
• TABLE 238 INDONESIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 158
• TABLE 239 INDONESIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 158
• TABLE 240 INDONESIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 159
• TABLE 241 INDONESIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 159
• TABLE 242 INDONESIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 159
• TABLE 243 INDONESIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 159
• TABLE 244 INDONESIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 160
• TABLE 245 INDONESIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 160
• TABLE 246 INDONESIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 160
• TABLE 247 INDONESIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 160
• TABLE 248 INDONESIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 161
• TABLE 249 INDONESIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 161
• TABLE 250 INDONESIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 161
• TABLE 251 INDONESIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 162
• TABLE 252 INDONESIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 162
• TABLE 253 INDONESIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 162
• TABLE 254 INDONESIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 163
• TABLE 255 INDONESIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 163
• TABLE 256 PHILIPPINES PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 164
• TABLE 257 PHILIPPINES SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 164
• TABLE 258 PHILIPPINES SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 165
• TABLE 259 PHILIPPINES SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 165
• TABLE 260 PHILIPPINES OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 166
• TABLE 261 PHILIPPINES OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 166
• TABLE 262 PHILIPPINES OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 166
• TABLE 263 PHILIPPINES PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 166
• TABLE 264 PHILIPPINES PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 167
• TABLE 265 PHILIPPINES PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 167
• TABLE 266 PHILIPPINES PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 167
• TABLE 267 PHILIPPINES PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 168
• TABLE 268 PHILIPPINES PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 168
• TABLE 269 PHILIPPINES PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 168
• TABLE 270 PHILIPPINES PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 169
• TABLE 271 PHILIPPINES PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 169
• TABLE 272 PHILIPPINES PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 169
• TABLE 273 PHILIPPINES PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 169
• TABLE 274 PHILIPPINES PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 170
• TABLE 275 PHILIPPINES PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 170
• TABLE 276 PHILIPPINES PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 170
• TABLE 277 PHILIPPINES PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 171
• TABLE 278 PHILIPPINES PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 171
• TABLE 279 PHILIPPINES PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 171
• TABLE 280 PHILIPPINES PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 171
• TABLE 281 PHILIPPINES PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 172
• TABLE 282 PHILIPPINES PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 172
• TABLE 283 REST OF ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 173

LIST OF FIGURES

• FIGURE 1 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: SEGMENTATION 29
• FIGURE 2 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: DATA TRIANGULATION 31
• FIGURE 3 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: DROC ANALYSIS 32
• FIGURE 4 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS 33
• FIGURE 5 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: COMPANY RESEARCH ANALYSIS 33
• FIGURE 6 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: INTERVIEW DEMOGRAPHICS 34
• FIGURE 7 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: MARKET END USER COVERAGE GRID 37
• FIGURE 8 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: DBMR MARKET POSITION GRID 38
• FIGURE 9 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: VENDOR SHARE ANALYSIS 39
• FIGURE 10 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: SEGMENTATION 42
• FIGURE 11 THE RISING PREVALENCE OF CHRONIC DISORDERS AND ADVANCEMENTS IN IMAGING TECHNIQUES ARE DRIVING THE GROWTH OF THE ASIA-PACIFIC PRECLINICAL IMAGING MARKET FROM 2023 TO 2030 43
• FIGURE 12 SYSTEMS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC PRECLINICAL MARKET IN 2023 AND 2030 43
• FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC PRECLINICAL IMAGING MARKET 49
• FIGURE 14 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY PRODUCT, 2022 56
• FIGURE 15 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY PRODUCT, 2023-2030 (USD THOUSAND) 57
• FIGURE 16 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY PRODUCT, CAGR (2023-2030) 57
• FIGURE 17 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY PRODUCT, LIFELINE CURVE 58
• FIGURE 18 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY REAGENTS, 2022 64
• FIGURE 19 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY REAGENTS, 2023-2030 (USD THOUSAND) 65
• FIGURE 20 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY REAGENTS, CAGR (2023-2030) 65
• FIGURE 21 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY REAGENTS, LIFELINE CURVE 66
• FIGURE 22 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY APPLICATION, 2022 72
• FIGURE 23 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND) 73
• FIGURE 24 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY APPLICATION, CAGR (2023-2030) 73
• FIGURE 25 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY APPLICATION, LIFELINE CURVE 74
• FIGURE 26 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY END USER, 2022 77
• FIGURE 27 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY END USER, 2023-2030 (USD THOUSAND) 78
• FIGURE 28 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY END USER, CAGR (2023-2030) 78
• FIGURE 29 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: BY END USER, LIFELINE CURVE 79
• FIGURE 30 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: SNAPSHOT (2022) 81
• FIGURE 31 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: COMPANY SHARE 2022 (%) 174